In the News

Behavioral intervention to increase physical activity led to lasting results at 3 years

At three outpatient diabetes clinics in Rome, Italy, participants who received specialized behavioral counseling sessions had greater increases in physical activity and decreases in sedentary time than those who received general physician recommendations.

Insulin initiation in the hospital associated with death, ED visits, readmissions in older patients

The study authors noted that older patients who begin insulin therapy while hospitalized are a vulnerable population for whom additional resources are needed during the transition to outpatient care.

SGLT2 inhibitors, GLP-1 receptor agonists compared for CV, renal outcomes

Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke.

MKSAP quiz: Type 1 diabetes management

This month's quiz asks readers to evaluate a patient with type 1 diabetes who is motivated to reduce her risks.

Spotlight on temperature and light

Recent studies looked at light therapy for depression and diabetes, seasonal variation in glycemic control, and associations between outdoor sunlight and temperature and metabolism.

In high-risk T2DM, canagliflozin reduced CV events regardless of baseline renal function

The results of the CANVAS trial are promising for patients with type 2 diabetes mellitus (T2DM) and early chronic kidney disease, but ongoing research should provide more convincing data, said an ACP Journal Club commentary.

FDA clears marketing of first interoperable insulin pump

The pump can be used with various components of diabetes therapy systems, including automated insulin dosing systems, continuous glucose monitors, and blood glucose meters.